BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6577861)

  • 1. Alteration of plasma membrane of drug-resistant tumor cells: 230-kilodalton protein identified by monoclonal antibody.
    Sugimoto Y; Suzuki H; Tanaka N
    Biochem Biophys Res Commun; 1983 Aug; 114(3):969-75. PubMed ID: 6577861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action and resistance of antineoplastic agents].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of membrane-associated enzymes in drug-resistant sublines of mouse lymphoblastoma L5178Y cells.
    Sugimoto Y; Nishimura T; Suzuki H; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1200-5. PubMed ID: 6173369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
    Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IgM pan-T monoclonal antibody that blocks E-rosette formation.
    De Nardin E; Tanigaki N
    Hybridoma; 1985; 4(2):125-41. PubMed ID: 3874145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.
    Suzuki H; Sugimoto Y; Tanaka K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):602-9. PubMed ID: 6547433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression behavior of 85-kDa membrane protein in adriamycin-resistant tumor cells and the inhibition of human tumor growth in athymic mice by MRK-20 monoclonal antibody against the protein.
    Ishii S; Naito M; Tsuruo T
    Jpn J Cancer Res; 1993 Jul; 84(7):776-82. PubMed ID: 8370652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
    J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
    Matsumura T; Sugimoto T; Sawada T; Amagai T; Negoro S; Kemshead JT
    Cancer Res; 1987 Jun; 47(11):2924-30. PubMed ID: 3567910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
    Chu TM; Kawinski E; Lin TH
    Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of hybridoma supernatants raised against membrane fractions from breast cancer using an immunodot assay.
    Heinsohn R; Seitz CR; Hollinshead AC; Hyun W; Poschmann A
    Cancer Detect Prev Suppl; 1987; 1():235-9. PubMed ID: 3480053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antibodies to probe membrane glycoproteins associated with drug-resistant J774.2 cells.
    Zeheb R; Beittenmiller HF; Horwitz SB
    Biochem Biophys Res Commun; 1987 Mar; 143(2):732-9. PubMed ID: 3551955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to immunogenic lymphoma cell variants displaying impaired neoplastic properties: characterization and applications.
    Hochman J; Park SS; Lazarovici P; Bergel M; Gottesman MM
    J Natl Cancer Inst; 1990 Dec; 82(23):1821-6. PubMed ID: 2250297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent expression of surface antigens in murine T-lymphoma cells. I. Quantitative analysis by SDS-PAGE of antigens from cells in different phases precipitated by antisera against membranes from synchronized cells.
    Reyero C; Waksman BH
    Exp Cell Res; 1980 Dec; 130(2):265-74. PubMed ID: 7449851
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; NovokhatskiÄ­ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.